Ready to revolutionize your approach to neurological research? This Sartorius guide offers expert guidance on harnessing the power of iPSCs for disease modeling. Gain practical tips, industry-leading solutions and insights into the future of neuroscience. Get your copy now! >>> https://bit.ly/3X6HaLJ
BioTechniques’ Post
More Relevant Posts
-
let's check this
Further to our post on Dana Hilts presentation at the Sachs Neuroscience Innovation Forum on 7 January, please click the link below to watch Dana's highly informative recap of the success of Xanamem and two near-term major Phase 2 readouts in Depression and Alzheimer's disease in 2024 and 2025 respectively. https://lnkd.in/gKr4MYBz
ACW CMO Dr Dana Hilt presents at Sachs Neuroscience Forum
https://www.youtube.com/
To view or add a comment, sign in
-
Check it below!
Further to our post on Dana Hilts presentation at the Sachs Neuroscience Innovation Forum on 7 January, please click the link below to watch Dana's highly informative recap of the success of Xanamem and two near-term major Phase 2 readouts in Depression and Alzheimer's disease in 2024 and 2025 respectively. https://lnkd.in/gKr4MYBz
ACW CMO Dr Dana Hilt presents at Sachs Neuroscience Forum
https://www.youtube.com/
To view or add a comment, sign in
-
Check this
Further to our post on Dana Hilts presentation at the Sachs Neuroscience Innovation Forum on 7 January, please click the link below to watch Dana's highly informative recap of the success of Xanamem and two near-term major Phase 2 readouts in Depression and Alzheimer's disease in 2024 and 2025 respectively. https://lnkd.in/gKr4MYBz
ACW CMO Dr Dana Hilt presents at Sachs Neuroscience Forum
https://www.youtube.com/
To view or add a comment, sign in
-
Great presentation
Further to our post on Dana Hilts presentation at the Sachs Neuroscience Innovation Forum on 7 January, please click the link below to watch Dana's highly informative recap of the success of Xanamem and two near-term major Phase 2 readouts in Depression and Alzheimer's disease in 2024 and 2025 respectively. https://lnkd.in/gKr4MYBz
ACW CMO Dr Dana Hilt presents at Sachs Neuroscience Forum
https://www.youtube.com/
To view or add a comment, sign in
-
Read this to gain insight
Further to our post on Dana Hilts presentation at the Sachs Neuroscience Innovation Forum on 7 January, please click the link below to watch Dana's highly informative recap of the success of Xanamem and two near-term major Phase 2 readouts in Depression and Alzheimer's disease in 2024 and 2025 respectively. https://lnkd.in/gKr4MYBz
ACW CMO Dr Dana Hilt presents at Sachs Neuroscience Forum
https://www.youtube.com/
To view or add a comment, sign in
-
Better to read this 😉
Further to our post on Dana Hilts presentation at the Sachs Neuroscience Innovation Forum on 7 January, please click the link below to watch Dana's highly informative recap of the success of Xanamem and two near-term major Phase 2 readouts in Depression and Alzheimer's disease in 2024 and 2025 respectively. https://lnkd.in/gKr4MYBz
ACW CMO Dr Dana Hilt presents at Sachs Neuroscience Forum
https://www.youtube.com/
To view or add a comment, sign in
-
Check this one
Further to our post on Dana Hilts presentation at the Sachs Neuroscience Innovation Forum on 7 January, please click the link below to watch Dana's highly informative recap of the success of Xanamem and two near-term major Phase 2 readouts in Depression and Alzheimer's disease in 2024 and 2025 respectively. https://lnkd.in/gKr4MYBz
ACW CMO Dr Dana Hilt presents at Sachs Neuroscience Forum
https://www.youtube.com/
To view or add a comment, sign in
-
Check this
Further to our post on Dana Hilts presentation at the Sachs Neuroscience Innovation Forum on 7 January, please click the link below to watch Dana's highly informative recap of the success of Xanamem and two near-term major Phase 2 readouts in Depression and Alzheimer's disease in 2024 and 2025 respectively. https://lnkd.in/gKr4MYBz
ACW CMO Dr Dana Hilt presents at Sachs Neuroscience Forum
https://www.youtube.com/
To view or add a comment, sign in
-
Check this
Further to our post on Dana Hilts presentation at the Sachs Neuroscience Innovation Forum on 7 January, please click the link below to watch Dana's highly informative recap of the success of Xanamem and two near-term major Phase 2 readouts in Depression and Alzheimer's disease in 2024 and 2025 respectively. https://lnkd.in/gKr4MYBz
ACW CMO Dr Dana Hilt presents at Sachs Neuroscience Forum
https://www.youtube.com/
To view or add a comment, sign in